Andrology Unit, Department of Life, Health and Environment Sciences, University of L'Aquila, Via Vetoio, L'Aquila, Italy.
Andrology. 2013 Jan;1(1):133-8. doi: 10.1111/j.2047-2927.2012.00010.x. Epub 2012 Oct 9.
The relationship between epididymis ultrasonography (US) and infertility is poorly defined probably owing to lack of objective and reproducible criteria of US evaluation. Here, we evaluated US size of testes, caput and of corpus epididymis in infertile men: 165 with total sperm count ≥39 × 10(6) , 187 with total sperm count <39 × 10(6) and 75 azoospermic men. Blood levels of follicle stimulating hormone (FSH) and of total testosterone were also evaluated. US measures obtained using a high-frequency (12 MHz) linear array transducer, included the mean value of bilateral testicular volumes (mL) (Testes-M), of bilateral longitudinal diameter of caput epididymis (mm) (Caput-M) and of the bilateral antero-posterior diameter of the corpus measured on a longitudinal scan (mm) (Corpus-M). Testicular histology of azoospermic men was obtained and the percentage of seminiferous tubules with elongated spermatids (%T) was used to classify cases with normal spermatogenesis (obstructive azoospermia) (n = 17; %T ≥ 80), or with deranged spermatogenesis (n = 58; %T ≤ 33). Caput-M was correlated with Testes-M (p = 0.0003; r = 0.17) and with FSH serum levels (p = 0.024; r = -0.14) but not with semen parameters. Caput-M but not Corpus-M values resulted greater in obstructive azoospermia compared with other groups, but difference was not significant. Cut-off values of Testes-M, Caput-M and of FSH correctly classified cases of obstructive azoospermia (AUC > 0.5). A patient with FSH < 7.8 IU/mL had a 63.6% chance (CI 40.1-83.2%) of being affected by obstructive azoospermia. US Caput-M ≥10.85 mm, which represented the cut-off value with the highest combination of sensitivity (58.8%, CI 32.9-81.6%) and specificity (91.4%, CI 81.0-97.1%) applied in cases with FSH < 7.8 IU/mL increased the probability for obstructive azoospermia from 63.6% up to 92.3% (CI 76.5-98.8%). US evaluation of the caput epididymis diameter helped in predicting the obstructive origin of azoospermia when FSH was not increased, whereas it was not relevant in non-azoospermic men.
附睾超声(US)与不育之间的关系定义不明确,可能是由于缺乏客观和可重复的 US 评估标准。在这里,我们评估了不育男性的睾丸、附睾头部和体部的 US 大小:165 名总精子计数≥39×10(6),187 名总精子计数<39×10(6)和 75 名无精子症男性。还评估了卵泡刺激素(FSH)和总睾酮的血液水平。使用高频(12MHz)线性阵列换能器获得的 US 测量值包括双侧睾丸体积(mL)(Testes-M)的平均值、双侧附睾头部的纵向直径(mm)(Caput-M)和在纵向扫描上测量的双侧体部的前后直径(mm)(Corpus-M)。对无精子症男性进行睾丸组织学检查,并使用具有伸长精子的精曲小管的百分比(%T)将具有正常生精功能的病例(梗阻性无精子症)(n=17;%T≥80)或具有生精障碍的病例(n=58;%T≤33)进行分类。附睾头部的大小与睾丸的大小(p=0.0003;r=0.17)和 FSH 血清水平(p=0.024;r=-0.14)相关,但与精液参数无关。与其他组相比,梗阻性无精子症患者的附睾头部大小(Caput-M)但不是体部大小(Corpus-M)更大,但差异无统计学意义。睾丸大小(Testes-M)、附睾头部大小(Caput-M)和 FSH 的截断值正确分类了梗阻性无精子症患者(AUC>0.5)。FSH<7.8IU/mL 的患者患有梗阻性无精子症的可能性为 63.6%(CI 40.1-83.2%)。当 FSH<7.8IU/mL 时,代表敏感性(58.8%,CI 32.9-81.6%)和特异性(91.4%,CI 81.0-97.1%)最高组合的 US 附睾头部大小(Caput-M)≥10.85mm,将梗阻性无精子症的概率从 63.6%提高到 92.3%(CI 76.5-98.8%)。当 FSH 没有增加时,附睾头部直径的 US 评估有助于预测无精子症的梗阻性原因,而在非无精子症男性中则没有相关性。